You are here: Industry Insights > COVID-19 vaccine

News List

US Govt. Invests $143M to Scale Up SiO2’s Primary Packaging Platform contractpharma
June 09, 2020
To accelerate capacity scale-up of advanced primary packaging platform for COVID-19 vaccines and therapeutics.
UQ, CEPI and CSL Partner on Development and Manufacture of COVID-19 Vax Candidate contractpharma
June 09, 2020
CSL appointed manufacturer for University of Queensland's "molecular clamp" enabled COVID-19 vaccine candidate.
AstraZeneca Takes Next Steps Towards Broad Access to Oxford’s COVID-19 Vaccine contractpharma
June 09, 2020
Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond.
AZ ramps up supply capacity for COVID-19 vaccine pharmatimes
June 08, 2020
AstraZeneca has sealed landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII) to broaden global access to the University of Oxford’s COVID-19 vaccine.
Intravacc forms alliance to develop intranasal Covid-19 vaccine pharmaceutical-technology
June 08, 2020
Dutch research and development vaccine institute Intravacc has collaborated with Wageningen Bioveterinary Research (WBVR) and Utrecht University to develop an intranasal vaccine against Covid-19.
AstraZeneca signs $750m Covid-19 vaccine manufacturing deal pharmaceutical-technology
June 08, 2020
straZeneca has signed a $750m agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi the Vaccine Alliance for the production, procurement and distribution of 300 million doses of the University of Oxford’s Covid-19 vaccine.
CSL teams up with CEPI and UQ for Covid-19 vaccine pharmaceutical-technology
June 08, 2020
Australia-based biotechnology company CSL has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Queensland (UQ) to advance the university’s Covid-19 vaccine.
Novavax Awarded DoD Contract for COVID-19 Vaccine contractpharma
June 08, 2020
Agreement includes a 2020 delivery of 10 million doses of NVX‑CoV2373 for DoD for Phase II/III trials or under an EUA if approved by the FDA.
AGC Biologics to produce Covid-19 vaccine adjuvant for Novavax pharmaceutical-technology
June 05, 2020
Novavax has selected AGC Biologics, a contract development and manufacturing organisation (CDMO), for large-scale manufacturing of an adjuvant for its Covid-19 vaccine candidate, NVX-CoV2373.
Novavax gets US defense funding for its COVID-19 vaccine expresspharma
June 05, 2020
The US-based company said the deal includes the delivery of 10 million doses of its COVID-19 vaccine - NVX‑CoV2373 - to the DoD this year.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page